fish oil
Commercial- Indications
- General health
Company intelligence / Profile preview
中润医药（集团）有限公司
广州市(Guangzhou), 广东省(Guangdong Province), 中国(China)linkedin.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
中润医药是一家以创新驱动的综合性制药企业，专注于抗病毒、急抢救、肿瘤及中枢神经系统等领域。公司拥有30余项研发管线，自2022年起多款产品获批上市，成为国内主流抗流感品种一线生产企业。代表产品包括感力清®磷酸奥司他韦颗粒、感力清®磷酸奥司他韦胶囊和韦力泰®帕拉米韦注射液。[1][2]
- Therapeutic areas
- OtherOncologyNeurologyInfectious Diseases
- Modalities
- Small moleculesHigh-end generics (including oral and injectable formulations)
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
NBL Pharmaceuticals of New Zealand for international expansion of health product portfolio.[5]
Beyond the preview
Go deeper on 中润医药（集团）有限公司.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 中润医药（集团）有限公司.